Effect of pain medication on driving performance.

Effect of dronabinol on actual driving, simulated driving and the Standardized Field Sobriety Test.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26737

Enrollment

Registered

2009-07-09

Start date

2009-09-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers, sedation, driving performance, dronabinol

Interventions

Dronabinol 10 and 20 mg, placebo.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 45 years; 2. Healthy volunteers; 3. BMI between 18 and 28; 4. Able to give a written informed consent; 5. Experience with cannabis use; 6. Valid driving license.

Exclusion criteria

Exclusion criteria: 1. History of drug abuse/addiction or psychiatric condition; 2. Pregnancy or lactation; 3. Cardiovascular abnormalities; 4. Hypertension; 5. Susceptibility of simulator sickness; 6. Allergy to sesame oil.

Design outcomes

Primary

Measure	Time frame
Standard deviation of lateral position in driving task.	—

Secondary

Measure	Time frame
1. Highway driving; 2. Car following; 3. Field sobriety tests; 4. Subjective measures.	—

Contacts

Public ContactJ.G. Ramaekers

Maastricht University Dept of Neuropsychology & Psychopharmacology, Faculty of Psychology and Neuroscience, P.O. Box 616

J.Ramaekers@psychology.unimaas.nl+31 (0)43 3881951

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)